##  [BYL719](/node/642216 "BYL719") 

  



Vijoyce®

[Oncology: Solid Tumors](/taxonomy/term/2771)

[Phase 3](/taxonomy/term/2776)

[≥ 2029](/taxonomy/term/11576)

[PI3K-alpha inhibitor](/taxonomy/term/2921)

 

Lymphatic malformations

[Supplementary Indication](/taxonomy/term/2791)



- [Print](/node/642216/printable/print)
- [PDF](/node/642216/printable/pdf)